• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Glenmark Pharmaceuticals Ltd.
    15 Aug 2025
    Board Meeting
    2030.70
    0.60%
    Glenmark Pharmaceuticals Q1 PAT down 86% dragged by US litigation settlement provision
    Business Line
    Consolidated total revenue from operations in Q1FY26 stood at 3,264.44 crore as against 3,244.19 crore in the same period a year ago.
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals Ltd. has gained 36.05% in the last 6 Months
    Glenmark Pharmaceuticals Q1 Results: Profit Plunges 86%
    NDTV Profit | 14 Aug 2025 1 more
    Glenmark Pharma Q1FY26 profit slumps 86% to 47 cr, revenue down 5%
    Business Standard | 14 Aug 2025
    logo
    Strides Pharma Science Ltd.
    14 Aug 2025
    839.40
    -0.74%
    Strides towards Naya Bharat
    Business Line
    Copy LinkShare onShare on Share on Share on
    Strides Pharma Science Ltd. is trading above its 200 day SMA of 745.6
    logo
    Anthem Biosciences Ltd.
    14 Aug 2025
    805.00
    -1.92%
    Recently listed biotech stock surges 44% against issue price; time to sell?
    Business Standard
    Shares of Anthem Biosciences surged 9 per cent to 820 on the BSE in Thursday's intra-day trade amid heavy volumes after reporting a strong earnings for the quarter ended June 2025.
    Copy LinkShare onShare on Share on Share on
    Anthem Biosciences Ltd. has gained 41.23% in the last 6 Months
    logo
    Shilpa Medicare Ltd.
    14 Aug 2025
    Drug Approval
    792.70
    -2.41%
    Shilpa Medicare share jumps 4% on 1:1 bonus issue; check record date here
    Business Standard
    Shilpa Medicare shares rose after the company announced a 1:1 bonus issue, with the Board approving the proposal in its meeting on August 13, 2025.
    Copy LinkShare onShare on Share on Share on
    Shilpa Medicare Ltd. is trading above its 200 day SMA of 783.4
    Shilpa Medicare Announces 1:1 Bonus Issue After Q1 Profit Triples Check Record Date
    NDTV Profit | 13 Aug 2025
    logo
    Lupin Ltd.
    13 Aug 2025
    US FDA Observation US FDA Approval
    1963.50
    -1.38%
    Mixed Q1 results for top drug firms amid price erosion, tariff threat
    Business Standard
    Fresh launches boosted growth for players like Lupin, Torrent
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    logo
    Pfizer Ltd.
    13 Aug 2025
    4977.00
    -0.56%
    Pfizer Q1 Results: Net Profit Climbs 27%, Margins Expand
    Pfizer Q1 Results: Net Profit Climbs 27%, Margins Expand
    NDTV Profit
    The drugmaker's bottom-line soared to Rs 191.75 crore during the April-June period, compared to Rs 150.71 crore for the same period last year.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading below its 30 day SMA of 5244.8
    logo
    Alkem Laboratories Ltd.
    12 Aug 2025
    Analyst Buy
    5508.00
    -1.22%
    Alkem to accelerate its non-US business as part of long-term growth plans: CEO
    Business Line
    Plans to set up a subsidiary in Saudi Arabia
    Copy LinkShare onShare on Share on Share on
    ICICI Securities Limited increased Buy price target of Alkem Laboratories Ltd. to 6400.0 on 19 Sep, 2025.
    Alkem Labs Q1 profit rises 22% to 664 cr on India, overseas sales growth
    Business Standard | 12 Aug 2025
    logo
    Granules India Ltd.
    12 Aug 2025
    530.15
    -0.12%
    Granules India's Q1 FY26 net profit down 1% at 112 cr
    Business Line
    The total revenue of the Hyderabad-based company increased 3 percent at 1210 crore in the quarter under review as against 1179 crore in the year-ago period
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. is trading above all available SMAs
    logo
    Natco Pharma Ltd.
    12 Aug 2025
    842.30
    -1.39%
    Natco Pharma's Q1 FY26 net down 28% at 480 crore
    Business Line
    The total revenue of the Hyderabad based company too declined at 1390 crore as against 1410crore in the year -ago period
    Copy LinkShare onShare on Share on Share on
    Geojit BNP Paribas decreased Hold price target of Natco Pharma Ltd. to 940.0 on 17 Sep, 2025.
    logo
    Lupin Ltd.
    12 Aug 2025
    US FDA Observation US FDA Approval
    1963.50
    -1.38%
    Lupin partners with Sandoz to commercialise ranibizumab in different markets
    Business Line
    Sandoz will oversee commercialisation of the product, while Lupin will be responsible for manufacturing and regulatory submissions
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading below its 30 day SMA of 1973.0
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • True Colors
    • Aptus Pharma
    • Solarworld Energy Solutions
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd